Work

Should a patient with HBV-DNA over 10,000 IU/ml receive antiviral therapy?

Year: 2026
Type: article
Abstract: Evidence shows that patients with CHB and HBV-DNA over 10,000 IU/ml should receive antiviral therapy due to its efficacy in reducing viral load and lowering the risk of liver disease complications.
Author: Tripdatabase
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: green
OpenAlex ID: W7235891729
FWCI:
Cites:
Cited by:
Related to: 10